Filter
1339
Filtered Results: 1339
Text search:
Cancer
surveillance
Featured
Recommendations
136
New Publications
354
Language
Document type
No document type
662
Studies & Reports
275
Guidelines
219
Strategic & Response Plan
77
Manuals
50
Fact sheets
29
Training Material
11
Situation Updates
9
Brochures
3
Resource Platforms
3
Infographics
1
Countries / Regions
Global
74
India
66
Kenya
55
Western and Central Europe
32
Latin America and the Carribbean
27
Ethiopia
26
Tanzania
26
Africa
26
Zambia
25
Malawi
23
South–East Asia Region
21
Nigeria
19
Uganda
19
Philippines
19
Burkina Faso
16
Senegal
16
South Africa
15
Ukraine
15
Nepal
14
Rwanda
14
Congo, Democratic Republic of
13
Ghana
13
Sierra Leone
12
Zimbabwe
12
Syria
12
Myanmar / Burma
12
Haiti
11
Bangladesh
11
Lesotho
11
Indonesia
10
Russia
10
Benin
9
Liberia
8
Cameroon
8
Namibia
8
Botswana
8
Middle East and North Africa
8
Asia
8
Eastern Europe
8
Cambodia
7
Eswatini/ Swaziland
7
East and Southern Africa
7
Eastern Europe and Central Asia
7
Niger
6
Brazil
6
Madagascar
6
West and Central Africa
6
Germany
5
Sudan
5
Yemen
5
Moldova
5
South Sudan
4
Jordan
4
Argentina
4
Peru
4
Paraguay
4
Tajikistan
4
Guinea
3
USA
3
Saudi Arabia
3
Togo
3
Somalia
3
Iraq
3
Lebanon
3
Turkey
3
China
3
Mozambique
3
Libya
3
Mexico
3
Western Pacific Region
3
Venezuela
3
Qatar
3
Kyrgyzstan
3
North America
3
France
3
Mali
2
Pakistan
2
Egypt
2
Thailand
2
Central African Republic
2
North Macedonia
2
Colombia
2
Bolivia
2
Chile
2
Albania
2
Laos
2
Bulgaria
2
Iran
2
Kazakhstan
2
Georgia
2
Vietnam
2
Belgium
2
Belarus
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Afghanistan
1
Chad
1
Mauritania
1
Papua New Guinea
1
Dominican Republic
1
Hungary
1
Cuba
1
Burundi
1
Honduras
1
Ecuador
1
El Salvador
1
Guatemala
1
Nicaragua
1
Sri Lanka
1
Other region
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Romania
1
Slovakia
1
Turkmenistan
1
Jamaica
1
Mauritius
1
Tunisia
1
Spain
1
Azerbaijan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
591
Public Health
124
Clinical Guidelines
123
Women & Child Health
47
Key Resources
31
Pharmacy & Technologies
13
Capacity Building
10
Toolboxes
COVID-19
140
HIV
102
AMR
63
NCDs
59
Mental Health
53
TB
52
Planetary Health
49
Global Health Education
34
Caregiver
34
Conflict
27
Refugee
23
Pharmacy
22
NTDs
20
Rapid Response
19
Disability
14
Ebola
10
Specific Hazards
7
Health Financing Toolbox
7
Natural Hazards
6
Polio
3
Cholera
2
Zika
2
Social Ethics
2
Une fois adoptée et mise en œuvre, la stratégie contribuera à réduire sensiblement les nouvelles infections sexuellement transmissibles et les décès connexes (ainsi que les mortinatalités et le cancer du col de l’utérus), tout en amélior...
The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer thera...
Study Report August 2014
Curatio International Foundation (CIF) and the Association Tanadgoma would like to acknowledge the financial support provided by GFATM under the project “Establishment of evidence base for national HIV/AIDS program by strengthening of HIV/AIDS ... system in the country” (GEO-H-GPIC), which made this study possible.
The report was prepared by Dr. Ivdity Chikovani, Dr. Natia Shengelia, Lela Sulaberidze (CIF) and Nino Tsereteli (Tanadgoma).
Special thanks are extended to international consultants – Ali Mirzazadeh (MD, MPH, PhD Postdoctoral Scholar, University of California, San Francisco Institute for Health Policy Studies & Global Health Sciences) for his significant contribution in study preparation, protocol and questionnaire design and data analysis and Abu S. Abdul-Quader (PhD, Epidemiologist, Global AIDS Program Centers for Disease Control and Prevention) for his valuable input in refining methodology and overall guidance during the study implementation.
Special thanks are extended to international consultants – Abu S. Abdul-Quader (PhD, Epidemiologist, Global AIDS Program, Centers for Disease Control and Prevention) for his valuable input in refining methodology and overall guidance during the study implementation and Ali Mirzazadeh (MD, MPH, PhD Postdoctoral Scholar, University of California, San Francisco Institute for Health Policy Studies & Global Health Sciences) for his significant contribution in the NSU study preparation, protocol and questionnaire design and data analysis.
Authors appreciate a highly professional work of Tanadgoma staff: the survey coordinator KhatunaKhazhomia; the interviewers: Ketevan Tchelidze, Nino Kipiani, Koba Bitsadze, Kakhaber Akhvlediani, ZazaBabunashvili, Rati Tsintsadze and the social workers: Archil Rekhviashvili, Tea Chakhrakia, Irina Bregvadze, Kakhaber Kepuladze, Ketevan Jibladze and Shota Makharadze for their input in the recruitment process.
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and death has been highest in older people and in persons with underlying noncommunicable diseases (NCDs), such as hypertension, cardiac diseas...
Ce plan intégré de lutte contre les MNT au Burkina Faso tient compte dans une large mesure des résultats de cette enquête et des cibles principales du nouveau plan mondial de lutte contre les MNT 2013-20201
. S’inscrivant dans la logique du PNDS, il s’est voulu multisectoriel et intègre tr...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing sur... systems for Severe Acute Respiratory Infection (SARI) to estimate COVID-19 vaccine effectiveness (VE) in preventing SARI associated with laboratory-confirmed SARS-CoV-2 using existing SARI surveillance systems. The approach uses the test-negative design to evaluate VE; cases are SARI patients who tested positive for SARS-CoV-2, and controls are SARI patients who tested negative for SARS-CoV-2.
Noncommunicable diseases (NCDs) are the principal cause of morbidity, disability and premature mortality in Azerbaijan. The most effective way to reduce the NCD burden is to prevent NCD development, by addressing thebehavioural risk factors underlying NCDs at the population and individual leve...
Regular physical activity is proven to help prevent and treat noncommunicable diseases (NCDs) such as heart disease, stroke, diabetes and breast and colon cancer. It also helps to prevent hypertension, overweight and obesity and can improve mental h...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, ..., chronic respiratory diseases, and diabetes.
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the world. Their drive...
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will help countries, regions, provinces or cities intendi...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic respiratory diseases, following the commitments made at...
Le document, intitulé « Progrès dans la prévention et le contrôle des maladies non transmissibles », rend compte des efforts mondiaux pour réduire l’impact des MNT (maladies non transmissibles), telles que les maladies cardiaques, le cancer...
The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and mu...
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past decade. It highlights that, while progress is being made, there is still much work to be done to create the infrastructure, policies, ... and health systems response that will allow NCDs and their contributing risk factors to be successfully contained and reversed.
